Data and Reproducibility

This journal is dedicated to upholding the principles of transparency and scientific rigor in all research published. Our policy on data availability aligns with best practices to promote openness and ensure the reproducibility of scientific findings. This includes adherence to recognized reporting guidelines and the registration of studies, including clinical trials, according to the norms of their respective fields. The journal follows the Core Practices established by the Committee on Publication Ethics (COPE). Data Availability Authors are strongly encouraged to make all data underlying their research findings publicly available, ensuring that readers can verify and reproduce results. Authors should provide clear and comprehensive details about the data collection, methodology, and analysis to facilitate this process. In some cases, the journal may request raw data for review. For Quantitative Research: Authors should deposit datasets in reputable data repositories or provide direct links to the data within the article. If the data cannot be made publicly accessible due to legal or ethical concerns, authors must provide an explanation and a mechanism to request access. For Qualitative Research: Authors should offer a detailed description of the data sources and methods used, including potential excerpts or representative examples to support their findings. Reporting Guidelines To enhance the clarity and completeness of research, authors should follow relevant reporting guidelines specific to their study design. These guidelines help ensure the consistency and transparency of research, making it easier for readers, reviewers, and editors to assess the validity of the study and its findings. Clinical Trial Registration For studies involving human participants, including clinical trials, authors are required to register their research in an appropriate clinical trial registry before participant enrollment. The journal adheres to the World Health Organization’s (WHO) International Clinical Trials Registry Platform (ICTRP) principles and supports the registration of clinical trials according to international standards. Reproducibility and Verification Reproducibility is central to scientific progress. Authors should include detailed methodologies, protocols, and analysis strategies in their manuscripts, allowing other researchers to replicate and validate the study's findings. This ensures the robustness and reliability of the results. Data Citation Proper citation of datasets and data sources is required to credit original authors and allow others to trace the data used in the research. Data citations should follow standard citation formats and be included in the reference list. Compliance Check The editorial board and reviewers will assess compliance with this data and reproducibility policy during the manuscript evaluation process. Authors may be asked to provide additional documentation or clarification regarding data availability or reporting practices. Policy Review This policy will be reviewed periodically and updated as needed to ensure alignment with the latest practices in data sharing, reporting, and reproducibility. Any revisions will be communicated to authors and made publicly available on the journal's website.